The Latest On Amarin - How Will The Investment Pay Off? [View article]
I think it will fall more tomorrow as the news spreads (I could be wrong though). If you are looking for an entry point I would be looking to get in under $9. No NCE will probably take it to the low 8's. Maybe lower, but not by much imo.
The Latest On Amarin - How Will The Investment Pay Off? [View article]
Wow...so glad I sold this crap today. Lucky me! :) Wake up and rely on your OWN research and critical thinking skills people. Mr. Rosenam you are a smart guy but you obviously know no more about this situation than the rest of us. Ive said it before and I'll say it again. Every since Vascepa was approved, you have been wrong on every call. EVERY call...you may still be proven right ultimately. But so far, you've stunk up the joint. This is why you don't blindly follow anyone's advice people. We are all in the same speculative boat.
Exelixis Traders Brace For Upcoming FDA Decision [View article]
He is obviously new to this. Im looking for it to hit around $6-$6.50 in pre-market, if and when it does, I'm out. Then it will probably open just under $6. Where it goes from there is anybody's guess. Price reaction to NDA acceptance/denial is one of the hardest things do predict imo. Look what happen to AVEO today.
Exelixis Traders Brace For Upcoming FDA Decision [View article]
$15? Really? A 120%-150% gain on a NDA acceptance? I dont think so. That may be possible, but it doesn't seem probable. At all. I can see $8. I doubt it will go much further than that. $12 seems waay too optimistic imo.
BioPharma Stocks On The Move Today And For The Rest Of The Week [View article]
Ok Scott last question and I'll leave you be. Do you think the short term catalyst upside potential for EXEL is higher? Or are you talking overall long term potential of the company? Im trying to figure out which short term catalyst will give me best return since they are both on the same day. I may just play them both.
The Latest On Amarin - How Will The Investment Pay Off? [View article]
And Steve Rosenman dupes us again. I have been following him since approval cause he portrays himself as someone "in the know" and so far every call he has made on the direction of Amarins share price, the direction of the company itself, and the NCE issue has been WRONG. Just plain wrong.
5 Bold Predictions For 2013 [View article]
Synergy Pharmaceuticals Stock Undervalued Ahead Of 3 Major Events [View article]
The Latest On Amarin - How Will The Investment Pay Off? [View article]
The Latest On Amarin - How Will The Investment Pay Off? [View article]
The Latest On Amarin - How Will The Investment Pay Off? [View article]
Exelixis Traders Brace For Upcoming FDA Decision [View article]
Exelixis Traders Brace For Upcoming FDA Decision [View article]
Acadia Pharmaceuticals And Galena Biopharma: What A Difference A Trial Design Can Make [View article]
BioPharma Stocks On The Move Today And For The Rest Of The Week [View article]
BioPharma Stocks On The Move Today And For The Rest Of The Week [View article]
Exelixis Traders Brace For Upcoming FDA Decision [View article]
The Latest On Amarin - How Will The Investment Pay Off? [View article]
The Latest On Amarin - How Will The Investment Pay Off? [View article]
The Latest On Amarin - How Will The Investment Pay Off? [View article]
The Latest On Amarin - How Will The Investment Pay Off? [View article]